Literature DB >> 2047791

Diagnosis of secondary depression in schizophrenia: implications for DSM-IV.

S G Siris1.   

Abstract

A substantial literature documents the existence of a secondary depression syndrome occurring in the course of schizophrenia. This review examines the relevance this syndrome may have in relation to demographic, symptomatic, biological, prognostic, and treatment issues. It explores the differential diagnosis of secondary depression in schizophrenia and considers the implications for the inclusion of such a diagnostic category DSM-IV.

Entities:  

Mesh:

Year:  1991        PMID: 2047791     DOI: 10.1093/schbul/17.1.75

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  17 in total

Review 1.  [Antidepressant effects of dopamine agonists. Experimental and clinical findings].

Authors:  M R Lemke
Journal:  Nervenarzt       Date:  2007-01       Impact factor: 1.214

Review 2.  rTMS strategies for the study and treatment of schizophrenia: a review.

Authors:  Arielle D Stanford; Zafar Sharif; Cheryl Corcoran; Nina Urban; Dolores Malaspina; Sarah H Lisanby
Journal:  Int J Neuropsychopharmacol       Date:  2008-02-01       Impact factor: 5.176

3.  [Developmental process of DGPPN quality indicators].

Authors:  I Großimlinghaus; P Falkai; W Gaebel; B Janssen; D Reich-Erkelenz; T Wobrock; J Zielasek
Journal:  Nervenarzt       Date:  2013-03       Impact factor: 1.214

Review 4.  First-episode schizophrenia: a focus on pharmacological treatment and safety considerations.

Authors:  Deanna L Kelly; Robert R Conley; William T Carpenter
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Interpersonal distances, coping strategies and psychopathology in patients with depression and schizophrenia.

Authors:  Alexander M Ponizovsky; Irena Finkelstein; Inna Poliakova; Dimitry Mostovoy; Nehama Goldberger; Paula Rosca
Journal:  World J Psychiatry       Date:  2013-09-22

6.  The relationships between depression and remission in first-episode psychosis.

Authors:  Piet Oosthuizen; Robin Emsley; Dana Niehaus; Liezl Koen; Bonga Chiliza
Journal:  World Psychiatry       Date:  2006-10       Impact factor: 49.548

7.  Suicidal behavior in the older patient with schizophrenia.

Authors:  John Kasckow; Lori Montross; Laurie Prunty; Lauren Fox; Sidney Zisook
Journal:  Aging health       Date:  2011-06

Review 8.  Postpsychotic depression in schizophrenia patients.

Authors:  Christian G Kohler; Elise A Lallart
Journal:  Curr Psychiatry Rep       Date:  2002-08       Impact factor: 5.285

Review 9.  Treatment refractory schizophrenia: how should we proceed?

Authors:  Z A Sharif
Journal:  Psychiatr Q       Date:  1998

10.  A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia.

Authors:  D C Goff; K K Midha; O Sarid-Segal; J W Hubbard; E Amico
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.